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Introduction 
Surgical site infection (SSI) is one of the major complica-
tions after spinal surgery [1]. Because it is a devastating
complication despite of its low incidence, there has been
much effort to prevent postoperative infection. Antibiotic
microbial prophylaxis (AMP) is one of major modalities to
prevent this malady. 
It is well known that the infection rate of a group that
received prophylactic antibiotics was significantly lower
than that of a group that did not receive prophylactic antibi-
otics when undergoing elective orthopedic surgery, includ-
ing spinal surgery [2,3]. Many studies have shown the
effectiveness of AMP in spinal surgery [4-7]. 
Regarding the dose of antibiotics, many studies also have
shown that there was no additional benefit with a multiple
dose regimen [8]. The current consensus is that antibiotic
administration should be started within 30 to 60 minutes
before skin incision. The current guideline for the preven-
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Study Design: This is a prospective randomized cohort study. 
Purpose: We intended to evaluate the efficacy of a 48 hour antibiotic microbial prophylaxis (AMP) protocol as compared
with a 72 hour AMP protocol. 
Overview of Literature: The current guideline for the prevention of surgical site infection (SSI) suggests the AMP should
not exceed 24 hours after clean surgery like spinal surgery. But there exist some confusion in real clinical practice about
the duration of postoperative antibiotic administration because the evidence of the guideline was not robust. 
Methods: The subjects were 548 patients who underwent spinal surgery at our department from April 2007 to December
2008. The patients were classified into two groups according to the prophylaxis protocol: group A, for which AMP was
employed for 72 hours postoperatively and group B, for which AMP was employed for 48 hours postoperatively. Five hun-
dred two patients out of 548 patients were followed until 6 months postoperatively. The incidence of SSI in the two groups
was analyzed. 
Results: The overall infection rate was 0.8%. There was no significant difference in infection rate between the two groups.
The overall infection rate for the patients who underwent instrumented fusion was 0.9%. There was no significant differ-
ence in the infection rate between the patients of the two groups who underwent instrumented fusion. 
Conclusions: AMP for 48 hours is as efficient as AMP for 72 hours.  
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tion of SSI that was published by the Center for Disease
Control and Prevention also suggests that postoperative
antibiotics should be discontinued within 24 hours after
clean surgery, including spinal surgery [1,9]. But there exist
some confusion in real clinical situations about the proper
duration of postoperative antibiotic administration because
the evidence of the guideline was not robust. 
Spinal surgery is classified as clean surgery [10] that
doesn’t need additional AMP for more than 24 hours post-
operatively, according to the guideline [11]. However, basic
research and clinical research has shown that surgery with
instrumentation has a higher risk of infection than that of
non-instrumented surgery [12-14], which might suggest that
a different AMP protocol is needed for instrumented proce-
dures compared with non-instrumented procedures. It is not
uncommon to use antibiotics for 72 hours after spinal
surgery even in the tertiary institutes in Korea. 
At our institute, we also administered prolonged antibi-
otics for 72 hours postoperatively before 2007. But we
changed our protocol and we have been administering
antibiotics for 48 hours or 72 hours postoperatively since
2007.   
This study purposes to determine the effectiveness of a 48
hour antibiotic prophylaxis protocol compared with that of a
72 hour antibiotic prophylaxis protocol. 
Materials and Methods 
The patients who were older than 15 years old and had
undergone clean spinal surgery by two orthopedic spinal
surgeons (LHM, MSH) were consecutively recruited from
April 2007 to December 2008. A total of 548 patients were
recruited.
From April 2007, two orthopedic spinal surgeons in our
institute have used two different prophylaxis protocols in all
their orthopedic spinal surgery. One used the protocol in
which the preoperative antibiotics start within 30 minutes
before skin incision and the antibiotics are administered
until 72 hours postoperatively (protocol A). Another proto-
col is that the preoperative antibiotics start within 30 min-
utes before skin incision and the antibiotics are adminis-
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Table 1. Demographic and surgical characteristics of patients 
Characteristic No. of patients (%) 
Age (mean [range], yr) 59.1 (16-86)  
Sex (female) 344 (62.2)  
Type of surgery 
Laminectomy only (including laminoplasty) 058 (10.5) 
Discectomy with laminectomy 141 (25.5) 
Arthrodesis with instrumentation 345 (62.4) 
Instrumentation only 009 (1.6) 
Operation region  
Cervical 032 (5.8) 
Thoracic 024 (4.3) 
Lumbar 497 (89.9) 
Table 2. Characteristics of two groups 
Characteristics
No. of patients (%)     
p-value  
Group A (n = 281) Group B (n = 221) 
Mean age (yr) 058.8 060.4 0.211a)
Body mass index 023.97 024.32 0.252a)
Sex (female) 173 (61.6) 145 (65.6) 0.350b)
Diabetes mellitus 047 (9.4) 047 (21.3) 0.195b)
Steroid use 013 (4.6) 008 (3.6) 0.576b)
Immunosuppressive agent use 009 (3.2) 005 (2.3) 0.525b)
Smoking 013 (4.6) 009 (4.1) 0.763b)
Alcohol abuse 009 (3.2) 008 (3.6) 0.798b)
Operating region 0.151c)
Cervical 019 (6.8) 010 (4.5)  
Thoracic 008 (2.8) 010 (4.5)  
Lumbar 247 (87.9) 200 (90.5) 
Thoracolumbar 007 (2.5) 001 (0.5) 
Multilevel surgeryd) 010 (3.6) 014 (6.3) 0.148b)
Instrumented arthrodesise) 130 (46.3) 194 (87.8) < 0.05b)
Revisional operation 004 (1.4) 002 (0.9) 0.699c)
a)From t-test, b)From Pearson chi-square test, c)From Fisher’s exact test, d)Three level or more, e)Statistically significant.
tered until 48 hours postoperatively (protocol B). Another
shot of antibiotics was injected if the time of the procedure
had exceeded 4 hours or the blood loss was over 1,000 ml
intraoperatively for both protocols. The Foley catheter was
routinely removed within 48 hours. There were 301 patients
(54.9%) in group A and 247 patients (45.1%) in group B.
First generation cephalosporins were used as prophylactic
antibiotics. 
The demographic and clinical characteristics that had
been previously reported as risk factors for SSI were
recorded. The demographic information and surgical char-
acteristics of the patients are summarized in Table 1. The
patients were followed until 6 months postoperatively to
detect surgical site infection.  
Comparison between the two groups was performed by
the t-test for continuous variables and the chi-square test for
categorical variables. The difference in the infection rate
between the two groups was determined by Fisher’s exact
test. 
Results
Forty six patients of the 548 patients (8.4%) were not fol-
lowed up until 6 months after surgery. The number of
patients who were not followed in groups A and B was 20
and 26, respectively. Five hundred two patients of the 548
patients were followed until 6 months after surgery. Among
them, there were 281 patients in group A and 221 patients
in group B.  
The mean age of the group A and group B patients was
58.8 and 60.4, respectively. There was no significant differ-
ence between the two groups (p = 0.211). The other vari-
ables of the two groups are shown in Table 2. There were
no significant difference between the two groups regarding
each variable, except for instrumentation and bone grafting.
The ratio of instrumented fusion to total surgery was higher
in group B and the difference of the ratios between the two
groups was statistically significant (p < 0.01).  
The overall incidence of SSI was 0.8% (4 of 502) (Table
3). The infection rate of group A was 0.4% (1 of 281). The
infection rate of group B was 1.4% (3 of 221). There was no
significant difference between the two groups (p = 0.325)
according to Fisher’s exact test. 
All the infections happened in the patients who received
lumbar instrumentation (three cases of instrumented lumbar
fusion; one case of lumbar instrumentation). Two of the
four cases of infection were classified as superficial inci-
sional; one case was classified as deep incisional infection
and 1 case was classified as organ space infection. Methi-
cilin-resistant Staphylococcous aureus was isolated in all 4
cases (Table 4).
We performed a sub-analysis for the cases with instru-
mented fusion (Table 5). The total number of cases with
instrumented fusion was 318 (127 in group A and 191 in
group B). The overall infection rate was 0.9% (3 of 318).
The infection rate of group A was 0.8% (1 of 127). The
infection rate of group B was 1.0% (2 of 191). There was no
significant difference of the infection rate between the two
groups (p = 1.000) according to Fisher’s exact test. In con-
trast, there was no infection among the 168 cases (147 in
group A; 21 in group B) that underwent decompression
without instrumentation or discectomy.
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Table 3. Infection rate 
Group No. of infection (%)  No. of non-infection Total   
A 1 (0.4) 280 281    
B 3 (1.4) 221 221 
Total 4 (0.8) 498 502 
Table 4. Detail information of infection cases 
Case Group Age/Sex Diagnosis Operation Cormobidity Category Organism
1 A 68/M Spinal stenosis, L3-4-5 Decompression and S/P pituitary  Organ space MRSA
instrumented fusion adenoma
2 B 50/M Metastatic spinal tumor, T11 Decompression and RCC Superficial    MRSA
instrumentation incisional 
3 B 67/ F Spondylolisthesis L4 PLIF and instrumentation None Deep incisional MRSA
4 B 53/M Spinal stenosis, L3-4-5 Decompression and None Superfical    MRSA 
instrumented fusion incisional 
M: Male, F: Female, S/P: Postoperative status, MRSA: Methicilin-resistant Staphylococcus aureus, RCC: Renal cell carcinoma,
PLIF: Posterior lumbar interbody fusion. 
Discussion 
SSI is diagnosis by the clinical signs and symptoms such
as fever, pain or purulent discharge on the operative site,
and the image findings. SSI is categorized into superficial
incisional infection, deep incisional infection and organ
space infection according to the Center for Disease Control
and Prevention guideline in 1999 [10]. Superficial incision-
al infection was defined as infection above the lumbodorsal
fascia and deep incisional infection was defined as infection
deep to the fascia. Organ space infection was defined as
discitis or osteomyelitis of the vertebra. 
The main cause of SSI following operations is bacterial
contamination of the surgical site during procedures [15].
However, only a small amount of bacterial contamination
can’t cause infection. It takes contamination with a substan-
tial number of bacteria to cause infection. Krizek and Rob-
son [16] demonstrated that contamination with more than
105 bacteria significantly increased the risk of wound infec-
tion. The role of antibiotic prophylaxis is to control the
number of contaminating bacteria below the significant
level that cannot cause infection, and not to eradicate all the
bacteria. Accordingly, the concentration of antibiotics
should be at the maximum when the skin is incised to con-
trol bacteria that are colonized on skin. To achieve this, the
antibiotics should be administered within 30 to 60 minutes
before skin incision [11,17]. 
Although preoperative antibiotic prophylaxis is effective
to prevent bacterial infection, prolonged use of antibiotics
cannot be justified. A meta-analysis by Barker [8] didn’t
identify any additional benefit of multiple-dose regimens.
Prolonged antibiotic use increases the risk of resistant
strains without any benefit [18]. In addition, the current
guideline for clean surgery is single dose antibiotic prophy-
laxis and if another dose is added, it should not exceed 24
hours postoperatively [10,11].
Despite of this consensus, the evidence for single dose
antibiotic prophylaxis is not robust, and especially for
orthopedic surgery with an implant [19]. Because a smaller
number of bacteria can cause infection with foreign material
[10], clean surgery with implantation has more of a risk for
infection. In addition, it might be appropriate to increase the
duration of prophylactic antibiotics for high risk patients
[20]. 
All this might cause confusion in the current clinical situ-
ation. For example, in Korea, the usual duration of prophy-
lactic antibiotics is more than 72 hours. We adopted our
current prophylactic antibiotics protocol since 2007 in our
institute. We adopted a 72 hour protocol and a 48 hour pro-
tocol for AMP to reduce antibiotic usage.    
The results of this study showed that there was no signifi-
cant difference of the infection rate between the 48 hour
group and the 72 hour group. The two groups were consec-
utively recruited, which is a popular method for conducting
clinical research to minimize a selection bias. However,
when the clinical characteristics of the 2 groups were com-
pared, the proportions of instrumented fusion of the two
groups were significantly different. We performed a sub-
analysis for the cases with instrumented fusion because
instrumented fusion might contribute to an increase risk for
infection [11,12,21]. 
Various clinical characteristics have previously been
reported as risk factors for surgical site infection. Olsen et
al. [14] stated that diabetes was the highest independent risk
factor for spinal SSI in their recent study. Suboptimal tim-
ing of prophylactic antibiotic therapy was another important
risk factor in their study. We routinely gave prophylactic
antibiotics just after positioning the patient, which was less
than 30 minutes before skin incision. However, we didn’t
check the exact time of administration. 
Fang et al. [20] showed that an advanced age, smoking,
diabetes, previous surgical infection, an increased body
mass index and alcohol abuse were risk factors for SSI. In
addition, instrumentation, steroid use, immunosupression,
multilevel surgery, lumbar surgery and revision operation
have also been reported as risk factors [10-12]. 
Many studies have reported that the infection rate of pos-
terior spinal fusion with instrumentation was higher than
that for other procedures. Massie et al. [12] reported that the
infection rate of instrumented fusion was 6% or more. In
contrast, the infection rate of discectomy was less than 1%
and it was 1-5% for spinal fusion without instrumentation in
their systemic review [12]. Perry et al. [21] reported a 9.7%
infection rate after segmental spinal instrumentation, which
was higher than the usual infection rate after spinal surgery,
and Wimmer et al. [22] reported that most infections
occurred with posterior instrumentation in their study. In
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Table 5. Infections in instrumented fusion group 
Group No. of infection (%) No. of non-infection Total  
Group A 1 (0.8) 126 127 
Group B 2 (1.0) 189 191 
Total 3 (0.9) 315 318
our study, all the infections were associated with posterior
instrumentation and 3 of the 4 infection cases were related
with posterior instrumented fusion. This result validates that
posterior instrumentation and instrumented fusion were
major risk factors for spinal SSI and it might suggest that
instrumented spinal surgery might have to be dealt with in a
different way in regard to AMP. 
The overall infection rate after spinal surgery has ranged
from 0.6% to 12.7% according to the previous studies [2-
4,8,11,13,14,18,23,24] The reported infection rate following
posterior spinal fusion with instrumentation has ranged
from 2.1% to 6% [5,12,14]. This study showed a consistent
result for the overall infection rate (0.8%) and it showed a
lower infection rate after instrumented fusion (0.9%) than
previsous studies, which was not statistically determined.  
This study has some limitations. First of all, the sample
size was relatively small. A large sample is needed for
strong statistical power, but this is difficult to achieve as the
incidence of SSI is very low. Dimick et al. [25] determined
that 5,036 patients would need to be enrolled to demonstrate
a 50% reduction in the infection rate, based on the assump-
tion that a wound infection rate of 2% is typical for spinal
surgery. The sample of this study also contained a small
number of high risk patients, such as patients with diabetes
mellitus, steroid use and smoking, which might impair the
ability to generalize the results of this sample to a larger
population. 
The second limitation is that the two groups, which had
different antibiotic prophylaxis protocols, underwent opera-
tion from different surgeons, although consecutive recruit-
ment was done.
The ratio of the types of procedures was different. The
ratio of the cases with instrumented fusion, which is a major
risk factor for surgical site infection, was higher in group B.
Accordingly, we performed a sub-analysis for the cases
with instrumented fusion, and there was no significant dif-
ference between the two groups. Future studies with larger
size samples are needed to confirm our results.  
Conclusions 
For clean spine surgery, AMP for 48 hours is as efficient
as AMP for 72 hours. 
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